FDA-approved Tuberculosis Regimen May Not Work for TB Meningitis
A US FDA-approved antibiotic regimen for multidrug-resistant (MDR) tuberculosis (TB) may not work for TB meningitis.
Category: Other Infections
Other Infections
Latest
Other Infections
Latest
‘Kraken’ Omicron Subvariant Quickly Spreading Through the US
A new COVID-19 subvariant -- XBB.1.5, known as the "Kraken" variant -- is quickly spreading through the United States and could soon become the dominant COVID strain circulating in the United States.
Other Infections
Latest
Penn Vet Team IDs Therapeutic Target After Respiratory Illness
Research IDs a factor responsible for inappropriate tissue regrowth after respiratory illness, pointing to a possible therapeutic target.
COVID-19: A Mucosal Vaccine Effective in Mice
A mucosal DNA vaccine is capable of ensuring the survival of a group of mice infected with a version of the virus adapted to this species.
Read More
FDA, CDC Authorize Bivalent COVID Vaccines for Children as Young as 6 Months Old
The US FDA recently updated its emergency use authorizations for bivalent Moderna and Pfizer-BioNTech COVID-19 vaccines to include use in children down to 6 months of age. The CDC signed off on the authorizations the following day.
Read More
COPD Patients at Greater Risk of COVID-19
COPD airway cells had a 24-fold greater infection with SARS-CoV-2 than healthy cells, according to a study published in the American Journal of Respiratory and Critical Care Medicine.
Read More
Vaccine Gives Substantial Protection Against COVID-19 Reinfection
Individuals previously infected with SARS-CoV-2, the virus that causes COVID-19, still benefit from vaccination, gaining 60% to 94% protection against reinfection, depending on the variant, according to a study in Plos Medicine.
Read More
How Ventilatory Support Has Changed During COVID-19
The COVID-19 pandemic has made business as usual a distant memory for many RTs, including the administration of respiratory support therapies like ventilation.
Read More
FDA Authorizes Moderna, Pfizer Bivalent Boosters for Children 5 and Older
The FDA has authorized bivalent COVID-19 vaccines from Moderna and Pfizer-BioNTech as a single booster dose in younger age groups, according to the agency.
Read More
COVID-19 Rebound Not Caused by Impaired Immune Response
Findings from a small study of eight patients published in Clinical Infectious Diseases suggest that COVID-19 rebound is likely not caused by impaired immune responses.
Read More
Voice App Accurately Detects COVID-19 Infection
Artificial intelligence (AI) can be used to detect COVID-19 infection in people’s voices by means of a mobile phone app.
Read More
Updated Bivalent Vaccines Authorized as COVID Boosters
The FDA authorized updated bivalent COVID vaccines from Moderna and Pfizer-BioNTech for use as single booster doses at least two months following primary or booster vaccination.
Read More
Moderna Submits Omicron-targeting Bivalent Booster Vaccine to FDA
Moderna Inc has completed its submission to the FDA for emergency use authorization for its BA.4/BA.5 Omicron-targeting bivalent booster vaccine, mRNA-1273.222.
Read More
Significant Increase in Type 2 Diabetes for Children During Pandemic
Johns Hopkins researchers have documented a steep rise in type 2 diabetes among children during the COVID-19 pandemic, likely due to “stay at home measures.
Read More
Is Nebulized Vaccine Delivery the Next Innovation?
Several new SARS-CoV-2 vaccines that target the respiratory system are in development, including one that uses a vibrating mesh to nebulize drops of vaccine doses.
Read More